CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Volume 13 Issue 4

Cyber Risk: How Can Pharma Avoid Black Swan Events?

Rod Schregardus, pharma manufacturing lead at The Access Group, looks at the IT security threats facing pharma companies today, and the steps that can be taken to pr...
Continue Reading →
Volume 13 Issue 4

How Technology Can Make Pharmaceutical Packaging Design an Easier Pill to Swallow

Packaging is one of the most vital components of modern commerce. It must define and promote a product and brand whilst being functional and providing relevant infor...
Continue Reading →
Volume 13 Issue 4

Operational Readiness – The Precursor to Operational Excellence

Following any tech transfer project, the subsequent startup of the manufacturing line is almost always full of challenges. The goal is to startup as soon as possible...
Continue Reading →
Volume 13 Issue 4

The Case for Smart, Real-time Quality Monitoring in Life Sciences Manufacturing

The more fragmented that processes become, the more critical it is that they can be assessed and managed for consistent quality. During the peak of the pandemic, as ...
Continue Reading →
Volume 13 Issue 4

Understanding the Challenges of Highly Potent Actives

A rising number of active pharmaceutical ingredients (APIs) are classed as “highly potent”. They are being increasingly harnessed by pharma companies developing oral...
Continue Reading →
Volume 13 Issue 4

Product Protection via Primary Packaging – Screwcaps to The Rescue

The use of screw caps to seal bottles for consumer use vary greatly from region to region. However, in North America, as in Europe, many medicines are sold in contai...
Continue Reading →
Volume 13 Issue 4

Ensuring Complete Product Packaging Quality

Liquid pharmaceutical manufacturers operate under great scrutiny and must set high standards of product quality. In three steps, Jürgen Kress, General Manager for Ch...
Continue Reading →
Volume 13 Issue 4

Delivering Efficiency on The Packing Line

The pharmaceutical industry has to deal with many of the same commercial pressures as other industries, and in many cases, the nature of the products means companies...
Continue Reading →
Volume 13 Issue 4

Prefillable Syringes in Deep Cold Storage: Is This The Way Forward for Mass Vaccinations?

The world has just witnessed the fastest vaccine rollout in modern medical history. This undoubtedly saved lives – but it placed intense pressure on our healthcare s...
Continue Reading →
Volume 13 Issue 4

The Importance of Clinical Trial Packaging and The Benefits in Outsourcing Your Small Molecule Packaging to a CDMO

Operating a clinical trial in what is a tightly regulated industry requires comprehensive, big picture thinking. Risks remain at all stages of the clinical supply ch...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026